equipped with a positive nitrogen pressure or vacuum, whereby appropriate application of positive nitrogen pressure generated sufficient bubbles for effective mixing for a coupling reaction while washing was achieved by pumping solvent through the resin bed. On the pre-loaded Wang resins the peptides were assembled from the C-terminus toward the N-terminus.
In the standard FastMoc protocol, the first step of the reaction was to remove the Fmoc protecting group from the preloaded amino acid using a solution of piperidine in NMP or DMF, followed by washing the resin bed with NMP or DMF. The next step was activation of the carbonyl group of the new amino acid (dissolved in NMP or DMF) using HBTU (dissolved in HOBt, DIPEA, and NMP or DMF). For a batchwise synthesis, HBTU: 2-4 eq. of the resin loading, HOBt: 2-4 eq. of the resin loading and DIPEA: 4-6 eq. of the resin loading were employed for activation. The activated amino acid was transferred from the activation vessel to the reaction vessel containing the previously deprotected amino terminal group of the peptide chain, and coupling was performed with vortex or sufficient nitrogen bubbling. To obtain the highest coupling efficiency, 2-4 times excess of each amino acid was used in each coupling. In the last step, the Fmoc protecting groups on the N-terminus were removed using a solution of piperidine in NMP or DMF, followed by washing the resin bed with NMP or DMF, MeOH and DCM.
In the cleavage step, the obtained peptide attached to the solid support was treated with a mixture of 95% TFA, 2.5% triisopropylsilane, and 2.5% water, and the mixture was stirred at room temperature for approximately 4 h, followed by filtration. The cleaved resin was washed three times with TFA. During the cleavage the side chain protecting groups (Boc) were removed by TFA. The obtained peptide solution was collected and concentrated by evaporating TFA under vacuum, followed by precipitating in cold diethyl ether. The crude product was separated by centrifugation and decanting the supernatant. The crude peptide was redissolved in HPLC grade water/acetonitrile co-solvent, then purified by reverse phase HPLC (Perkin Elmer 200). The eluents for the preparative HPLC were 0.1% TFA in HPLC grade water and 0.1% TFA acetonitrile. During HPLC a gradient solvent was used, where the acetonitrile portion increased linearly from 0% to 90% over 20 min and then decreased linearly to 0% over 10 min. A sample injection (injected with Perkin Elmer 
Synthesis of Peptide I
The complete sequence of the peptide was GABA-GABA-Lys-Leu-Val-Phe-Phe. It was assembled from the C-terminus towards the N-terminus, which was performed with a fully automated peptide synthesizer (433A Applied Biosystems). Pre-loaded purified by RP-HPLC (RP-HPLC retention time = 12.37 min), followed by lyophilization to give a white solid.
[001] MS(ESI)m/z for C 43 
Synthesis of Peptide II
The complete sequence of the peptide was β-Ala-β-Ala-Lys-Leu-Val-Phe-Phe. It was assembled from the C-terminus towards the N-terminus, which was performed with a fully automated peptide synthesizer (433A Applied Biosystems). Pre-loaded resin 
Synthesis of Peptide III
The complete sequence of the peptide was
It was assembled from the C-terminus towards the N-terminus, which was performed with a fully automated peptide synthesizer (433A Applied Biosystems). Pre-loaded resin Table 1 . These samples were then incubated for four days. After the period of incubation, the concentration of solutions containing ThT, was reduced by a factor 4 through dilution in Tris buffer. The fluorescence of these samples was then measured using λ ex = 440 nm. The fluorescence data were corrected for Tris buffer background.
Synthesis of Peptide

Cryogenic Transmission Electron Microscopy
Experiments were performed at Unilever Research, Colworth, Bedford, UK. Sample preparation was carried out using a CryoPlunge 3 unit (Gatan Instruments) employing kV and imaged using a Gatan Ultrascan 4000 camera and images captured using DigitalMicrograph software (Gatan).
X-ray Diffraction
X-ray diffraction was performed on stalks prepared from 2 wt% solutions in water.
The stalks were mounted (vertically) onto the four axis goniometer of a RAXIS IV++ X-ray diffractometer (Rigaku) equipped with a rotating anode generator. The XRD data was collected using a Saturn 992 CCD camera.
Fourier Transform Infra-Red (FTIR) Spectroscopy
Peptides were dissolved in D 2 O. Spectra were measured on a Nicolet Nexus spectrometer with DTGS detector. Solutions of peptide were sandwiched between two For the binding studies, CD spectra were calculated for each molar ratio of to peptide I, III, IV or V. The CD spectra were calculated based on addition of spectra of the components (Aβ(1-42) and peptides) on a molar ellipticity basis using the molar concentrations for the mixtures for which CD spectra were measured.
The post-acquisition smoothing tool from Chirascan software was used to remove random noise elements from the averaged spectra. A residual plot was generated for each curve in order to verify whether or not the spectrum has been distorted during the smoothing process. The CD signal from the solvent was subtracted from the CD data of the peptide solutions. Following background correction, the CD data were normalized to molar mean residue ellipticity. (2) a) As it was prepared from a more concentrated solution (since stalks could not be prepared from more dilute solution), this sample exhibits many more reflections. 
